Roche, Ionis RNA drug scores in kidney disease study

AI Summary

Roche and Ionis have reported promising results for a new RNA-based drug targeting IgA nephropathy, a kidney disease attracting significant attention from pharmaceutical companies. These results could pave the way for a novel therapeutic approach to the condition.

The results position Roche to bring a new kind of medicine to market for IgA nephropathy, a disease that’s drawn considerable attention of late from drugmakers.